Patients receiving neuromuscular blocking medications as part of their anesthetic regimen should be carefully monitored to ensure the best care and outcomes, according to recent—and independently ...
Uppsala, Sweden, December 10, 2025. Senzime AB (publ) today announced the launch of the latest series of innovative features for its next-generation TetraGraph ® system. The new EMGINE TM Sirius ...
UPPSALA, SE / ACCESS Newswire / October 8, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime AB (publ) today announced the launch of EMGINETM, a proprietary software suite for its next-generation ...
The latest guidance in addressing proper monitoring and reversal of neuromuscular blockade drugs during general anesthesia—a major advance in patient safety and satisfaction—was published today in ...
(MENAFN- GlobeNewsWire - Nasdaq) The global neuromuscular transmission monitor market growth is driven by increasing ICU admissions, rising surgical volumes, and technological advancements in ...
Muscle relaxants are a necessary part of anesthesia during certain major operations. Studies have, however, hinted at respiratory risks connected with these drugs. A major new study has confirmed the ...
An ED physician ordered a neuromuscular blocking agent to sedate a combative patient. However, a nurse administered the drug too soon, before the patient could be intubated. The patient arrested and ...
UPPSALA, SE / ACCESS Newswire / December 10, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime AB (publ) today announced the launch of the latest series of innovative features for its next-generation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results